Expertise in
4
conditions

Szu-min M. Hsieh

No. 7 Chung Shan South Road, 
TPQ, TW 
Expertise in
4
conditions
No. 7 Chung Shan South Road, 
TPQ, TW 

Overview

Szu-min Hsieh practices practicing medicine in Taiwan.

Hsieh is highly rated in 4 conditions, according to our data. Their clinical expertise encompasses Hepatitis A, HIV/AIDS, Syphilis, and Hepatitis.

They are actively involved in clinical research, co-authoring 91 peer reviewed articles and participating in 4 clinical trials.

Locations

No. 7 Chung Shan South Road, TPQ, Taiwan
Other Locations
7 Chung Shan South Road, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase II, Prospective, Randomized, Double-Blind, Dose-Comparison, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901 in Elderly Adults
A Phase II, Prospective, Randomized, Double-Blind, Dose-Comparison, Multi-Center Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901 in Elderly Adults
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Biological
Study Phase: Phase 2
A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers
A Randomized, Single Center, Open-label, Dose-finding, Phase I Study to Evaluate the Safety and Immunogenicity of Pandemic Virus Vaccine, AdimrSC-2f (SARS-CoV-2), in Healthy Volunteers
Enrollment Status: Completed
Publish Date: May 24, 2022
Intervention Type: Biological
Study Drug: AdimrSC-2f Vaccine
Study Phase: Phase 1
A Phase II, Prospective, Double-blinded, Multi-Center, Multi-Regional Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901
A Phase II, Prospective, Double-blinded, Multi-Center, Multi-Regional Study to Evaluate the Safety, Tolerability, and Immunogenicity of the SARS-CoV-2 Vaccine Candidate MVC-COV1901
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Biological
Study Phase: Phase 2
A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901
A Phase I, Prospective, Open-Labeled Study to Evaluate the Safety and Immunogenicity of MVC-COV1901
Enrollment Status: Completed
Publish Date: January 31, 2022
Intervention Type: Biological
Study Drugs: MVC-COV1901 Vaccine, CpG 1018 Adjuvant
Study Phase: Phase 1
View 3 Less Clinical Trials

91 Total Publications

Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study.
Two-year durability of MVA-BN vaccine-induced antibodies and the risk of Mpox breakthrough infections among high-risk populations: a prospective, longitudinal study.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: May 04, 2026

Frequently Asked Questions about Szu-min M. Hsieh

Is Szu-min M. Hsieh a top-rated expert for Hepatitis A?

MediFind is an objective health platform that identifies experts based on real-world data. Szu-min M. Hsieh is classified as an Distinguished expert for Hepatitis A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Szu-min M. Hsieh participate in research or clinical trials?

Yes. Szu-min M. Hsieh has published 91 articles and abstracts on conditions like Hepatitis A. You can view a list of Szu-min M. Hsieh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Hsieh's expertise for a condition
ConditionClose
    View All 16 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile